Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDO2 | P48775 | 10/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.64 |
| ▸ | GABRP | O00591 | 1/20 | 0.64 |
| ▸ | GABRD | O14764 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.64 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.64 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.64 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.64 |
| ▸ | MAOA | P21397 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27817460 | 0.85 | TDO2 (0.80) | TDO2KDM4EMEN1MAPTMAPK1 | |
| SCHEMBL20600847 | 0.78 | BCHE (0.51) | TDO2KDM4EMEN1MAPTMAPK1 | |
| SCHEMBL29543498 | 0.78 | TDO2 (0.64) | TDO2KDM4EMEN1MAPTMAPK1 | |
| Harman SCHEMBL141723 | 0.78 | MAOA (1.00) | TDO2KDM4EMEN1MAPTMAPK1 | |
| SCHEMBL7546861 | 0.78 | TDO2 (0.64) | TDO2KDM4EMEN1MAPTMAPK1 | |
| SCHEMBL28902870 | 0.78 | TDO2 (0.64) | TDO2KDM4EMEN1MAPTMAPK1 | |
| SCHEMBL1798020 | 0.78 | TDO2 (0.64) | TDO2KDM4EMEN1MAPTMAPK1 | |
| SCHEMBL21714667 | 0.78 | TDO2 (0.64) | TDO2KDM4EMEN1MAPTMAPK1 | |
| SCHEMBL10020899 | 0.78 | TDO2 (0.64) | TDO2KDM4EMEN1MAPTMAPK1 | |
| Harman SCHEMBL9480937 | 0.78 | MAOA (1.00) | TDO2KDM4EMEN1MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118726995-A | Method for constructing dehydroevodiamine by utilizing electrochemical oxidative carbonylation reaction | 桂林理工大学 | 2024-10-01 | — | — | CN | claimed |
| CN-105753860-B | β carboline alkaloids and its application in antineoplastic is prepared | 兰州大学 | 2018-03-06 | — | — | CN | claimed |
| US-20260059997-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-02-26 | — | — | US | disclosed |
| CN-118726995-B | Method for constructing dehydroevodiamine by utilizing electrochemical oxidative carbonylation reaction | 桂林理工大学 | 2025-10-03 | — | — | CN | disclosed |
| CN-116789666-B | Compound and application thereof in preparation of antitumor drugs | 鲁东大学 | 2025-02-07 | — | — | CN | disclosed |
| US-20250011343-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2025-01-09 | — | — | US | disclosed |
| CN-118726995-A | Method for constructing dehydroevodiamine by utilizing electrochemical oxidative carbonylation reaction | 桂林理工大学 | 2024-10-01 | — | — | CN | disclosed |
| CN-118726995-A | Method for constructing dehydroevodiamine by utilizing electrochemical oxidative carbonylation reaction | 桂林理工大学 | 2024-10-01 | — | — | CN | disclosed |
| EP-4419533-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | Samsung Display Co., Ltd. (KR) | 2024-08-28 | — | — | EP | disclosed |
| CN-118215668-A | Organic molecules for optoelectronic devices | 三星显示有限公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-116789666-A | Compound and application thereof in preparation of antitumor drugs | 鲁东大学 | 2023-09-22 | — | — | CN | disclosed |
| WO-2023068786-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-04-27 | — | — | WO | disclosed |
| CN-104755078-A | Application of harmine derivatives in preparation of antimicrobial agents | XINJIANG HUASHIDAN PHARMACEUTICAL RES CO LTD | 2015-07-01 | — | — | CN | disclosed |
| CN-101429198-B | Banisterine derivant and uses thereof | XINJIANG HUASHIDAN MEDICAMENTS RES CO LTD | 2013-10-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260059997-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, GLRB, GLRA1 | TDO2 3219/4885KDM4E 2879/4885MEN1 3737/4885 |
| US-20250011343-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | OR10J3, C1R, ORC3 | TDO2 597/4885KDM4E 4368/4885MEN1 3797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.